Corporate Inversion Excise Tax — Expatriated Entities (§ 4985)

A corporate inversion occurs when a U.S. corporation restructures to place a foreign parent company on top of its corporate structure — technically reincorporating abroad while maintaining its U.S. business operations — primarily to reduce U.S. tax liability. Congress responded with a two-pronged approach: § 7874 limits the tax benefits of inversions (treating the foreign parent as a U.S. corporation if the former shareholders own too much of the new foreign entity), and § 4985 imposes a 15% excise tax on the value of stock-based compensation received by "disqualified individuals" (insiders — executives, directors, and certain highly compensated employees) of an "expatriated corporation" during the inversion period. The § 4985 excise operates separately from the § 7874 anti-inversion rules and is designed to ensure insiders don't benefit from tax-free capital gains on their stock compensation when their company inverts. For the related excise on excess executive compensation in change-of-control transactions, see golden parachute excise tax (§ 280G). For how TCJA's GILTI and FDII regimes changed the economics of inversions, see international tax — GILTI and FDII.

Current Law (2026)

Legal Authority

• 26 U.S.C. § 4985(a) — Imposes the 15% excise tax: any disqualified individual of an expatriated corporation who receives specified stock compensation in connection with the inversion must pay 15% excise tax on the value of that compensation; the tax is imposed on the individual, not the corporation
• 26 U.S.C. § 4985(b) — Liability for tax: the corporation is jointly and severally liable for the tax if it fails to deduct and withhold the 15% from the individual's compensation; creates a practical obligation for the corporation to collect the tax at payment
• 26 U.S.C. § 4985(c) — Definitions: "disqualified individual" means any individual who is an officer, director, or beneficial owner of more than 1% of any class of stock of the corporation, or who is a highly compensated employee; "specified stock compensation" includes stock options, restricted stock, restricted stock units, phantom stock, stock appreciation rights, and substantially similar instruments
• 26 U.S.C. § 4985(d) — Special rules: the tax applies to compensation held during the 12-month period beginning 6 months before the inversion date; compensation that is forfeited before the inversion completes does not trigger the excise
• 26 U.S.C. § 7874 — The companion anti-inversion statute: if a foreign corporation acquires substantially all the properties of a U.S. corporation and former shareholders own 80%+ of the foreign acquiring corporation, the foreign corporation is treated as a U.S. corporation for all U.S. tax purposes (full inversion block); at 60–79% ownership, certain tax benefits are denied

How It Works

Before the 2004 American Jobs Creation Act and subsequent Treasury regulations, U.S. multinationals could dramatically reduce their global tax burden by reincorporating in a low-tax jurisdiction — Ireland, the Cayman Islands, Bermuda — while keeping their U.S. operations unchanged. Pfizer, Medtronic, and dozens of others executed or attempted inversions. § 7874 targets the corporate structure: if the former U.S. shareholders own 60–79% of the foreign acquiring entity, it becomes a "surrogate foreign corporation" — certain U.S. tax benefits are denied. If they own 80%+, the foreign corporation is fully treated as a U.S. domestic corporation — the inversion fails from a tax perspective entirely. The § 4985 excise addresses insider compensation: when a U.S. corporation completes an inversion qualifying as an "expatriation" under § 7874, executives, directors, and major shareholders who hold stock options, restricted stock, or deferred compensation during the 12-month window centered on the inversion date owe a 15% excise tax on that compensation regardless of whether it has vested or been exercised. The corporation must withhold the tax; failure to withhold creates joint and several liability.

Post-2016 Treasury regulations (T.D. 9761) tightened the § 7874 rules by disregarding certain "built-in" assets when measuring ownership percentages — making it harder to structure a transaction that achieves the 60% threshold that would at least yield surrogate foreign corporation treatment. The practical power of these regulations was demonstrated dramatically in April 2016, when Treasury issued emergency anti-inversion guidance and Pfizer and Allergan — hours later — called off their planned $160 billion merger, one of the largest corporate deals in history. The episode illustrated how § 4985 and § 7874 work together with Treasury's regulatory authority to deter inversions through a combination of structural failure (the 80% rule), benefit denial (the 60–79% zone), and executive-compensation tax costs that make the transaction economics unappealing even when the corporate restructuring itself can be completed.

How It Affects You

If you're a corporate executive at a company considering or executing an inversion: The § 4985 excise creates a direct, personal tax liability — 15% on the full value of all specified stock compensation you hold during the 12-month inversion window (the 6 months before and 6 months after the inversion date), including unvested RSUs, unexercised stock options, phantom stock, stock appreciation rights, and deferred compensation tied to company equity. This tax is imposed on you personally, not on the company — though the company is required to withhold it and becomes jointly and severally liable if it doesn't. The math can be severe on large equity positions: a $10 million unvested RSU portfolio triggers $1.5 million in excise tax before you've received a dollar of the underlying compensation. Unlike the § 280G golden parachute excise (triggered by change in control), § 4985 fires at the reincorporation event itself — not on acceleration or payout. The corporation cannot gross you up for this tax on a deductible basis (§ 275 prohibits the deduction). Model your § 4985 exposure with M&A counsel and your personal tax advisor before the deal closes — post-closing, the analysis is academic.

If you're a corporate attorney or M&A professional structuring a cross-border deal: The § 4985 analysis is one piece of a multi-statute anti-inversion review. The threshold question is § 7874: if former U.S. shareholders will own 80%+ of the acquiring foreign corporation after the deal, the foreign corporation is treated as a U.S. corporation for all U.S. tax purposes — the inversion fails entirely. At 60–79% ownership, the transaction becomes a "surrogate foreign corporation" arrangement: certain U.S. tax attributes are stripped, but full domestic treatment is avoided. The 2016 Treasury regulations (T.D. 9761, finalized 2020) tightened the ownership calculation by disregarding "cash box" assets (foreign cash pools used to inflate the non-U.S. shareholder percentage) and stepping through transaction sequences — so pro forma ownership calculations must be run under the current regs, not pre-2016 assumptions. For deals near the 60% or 80% thresholds, the § 4985 exposure and § 7874 risk interact: a deal that clears the 80% test still triggers § 4985 for insiders if it crosses 60%. Also analyze the § 280G interaction — change-in-control payments in connection with the inversion may be "parachute payments" triggering a parallel 20% excise analysis for the same executive compensation package.

If you're a shareholder in a U.S. company evaluating a cross-border merger: Post-TCJA and post-§ 7874, full corporate inversions offer essentially no remaining U.S. tax benefit for most companies — and come with real costs. § 4985 taxes insiders, § 7874 may eliminate the foreign tax benefit entirely, GILTI imposes a minimum tax on foreign income regardless of jurisdiction, and reputational and Congressional scrutiny can follow. The deals that defined the 2014–2016 inversion wave — Medtronic-Covidien, AbbVie-Shire, Pfizer-Allergan's $160 billion cancelled deal — have not been replicated at scale. What has replaced inversions for international tax efficiency: legitimate IP migration to Ireland, Singapore, or the Netherlands (governed by transfer pricing arm's-length standards), FDII deductions for U.S.-based IP serving foreign markets, and TCJA's 21% corporate rate (which narrowed the U.S.-to-offshore differential). For shareholders evaluating M&A scenarios, if a deal involves a cross-border merger, check the acquirer's Form S-4 or proxy statement — filed with the SEC at sec.gov/edgar — for required disclosure of § 7874 analysis and any material U.S. tax consequences of the transaction structure.

If you're a tax researcher, policy analyst, or Treasury/IRS practitioner tracking anti-inversion law: The § 4985 / § 7874 framework is in an unusual equilibrium — rarely triggered since 2016, but structurally important as a deterrent and analytically complex in edge cases. The OECD Pillar Two global minimum tax (15% minimum rate, implemented in 40+ jurisdictions starting 2024) has further changed the economics by imposing a top-up tax in formerly attractive low-tax jurisdictions like Ireland, eroding one of the primary inversion destinations and raising questions about whether § 7874 needs updating for the post-Pillar-Two environment. Treasury's § 7874 regulations were largely finalized in 2020; open questions involve partnership-based structures and certain non-ordinary-course transactions. For legislative tracking, the BUILD Act and similar bills to lower the § 7874 80% threshold have been introduced in multiple Congresses but not enacted. The Tax Policy Center (taxpolicycenter.org), Tax Foundation (taxfoundation.org), and Joint Committee on Taxation staff studies and Blue Books at jct.gov/publications are the authoritative sources for § 4985 and § 7874 legislative history and policy analysis.

State Variations

§ 4985 is a federal excise tax; states do not have an equivalent. However, state income taxes on stock compensation — when it eventually vests or is exercised — are unaffected by the federal excise. California, New York, and other high-income-tax states continue to tax the income from stock compensation regardless of whether the 15% federal excise has been paid. The 15% excise is not deductible for federal income tax purposes under § 275.

Pending Legislation

• Corporate inversion reform: The OECD Pillar Two global minimum tax (15% minimum corporate rate, in effect in 140+ countries) significantly changes the economics of corporate inversions by making low-tax jurisdictions less attractive. As Pillar Two implementation matures, the anti-inversion rules may need to be updated to address new structures.
• BUILD Act / Stop Corporate Inversions: Legislation to further tighten § 7874 rules has been introduced in multiple Congresses; these bills generally seek to lower the 80% threshold that triggers full inversion treatment, or to disregard certain transaction structures entirely.

Recent Developments

• Inversion activity collapsed after 2016 and hasn't revived: The combination of the April 2016 Treasury emergency regulations, TCJA's reduction of the U.S. corporate rate to 21%, and the GILTI minimum tax on foreign income effectively ended large-scale corporate inversions. § 4985 is rarely triggered today — most major cross-border M&A is structured carefully to keep former U.S. shareholders below the § 7874 60% threshold, or to structure deals as genuine foreign acquisitions rather than inversions. The high-profile deals that defined the 2014–2016 inversion wave (Medtronic-Covidien, AbbVie-Shire, Pfizer-Allergan cancelled) have not been replicated at scale.
• OECD Pillar Two (global minimum tax) changed inversion economics further: The OECD/G20 Pillar Two framework, implemented by the EU, UK, Australia, Japan, and approximately 40 other countries starting in 2024, imposes a 15% global minimum corporate tax on multinationals with revenues above €750 million. For U.S. companies, Pillar Two creates an ironic reversal: Ireland's 12.5% rate (historically attractive for inversions) is now supplemented by a Pillar Two top-up tax to 15% in many cases, reducing the residual advantage. As Pillar Two implementation matures, some of the remaining anti-inversion rules may need to be updated to account for the changed international tax environment.
• Treasury § 7874 regulations remain an active area: The Treasury has continued to issue guidance on the § 7874 anti-inversion rules, particularly regarding the treatment of "cash boxes" (foreign acquiring corporations with large pools of foreign cash that inflate the non-U.S. shareholder percentage) and certain partnership-based inversion structures. The 2016 temporary regulations were largely finalized in 2020. Tax practitioners must stay current on IRS guidance as multinationals consider cross-border restructurings short of formal inversions — particularly IP migration and holding company structures.
• § 4985 interaction with expanded § 162(m) remains relevant for inverted companies: For the small number of companies that complete transactions triggering § 4985 exposure, the interaction with § 162(m)'s $1 million deduction limitation for covered executive compensation requires careful modeling. Compensation paid as the excise tax under § 4985 is not deductible by the corporation (§ 275), and the underlying stock compensation may also be subject to § 162(m) non-deductibility. Multi-layered executive compensation tax analysis is essential in any qualifying inversion transaction.